Compare Stocks

→ Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CZO Ceapro	C$0.26 +8.3%	C$0.23	C$0.15 ▼ C$0.64	C$20.36M	1.39	50,465 shs	72,000 shs

10 Best Stocks to Own in 2024

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CZO Ceapro	+8.33%	+6.12%	+10.64%	+62.50%	-54.39%

Protect Yourself While There’s Still Time … (Ad)

The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.

4 simple steps to protect your privacy and money before it’s too late.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CZO Ceapro	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CZO Ceapro	N/A	N/A	N/A	N/A

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CZO Ceapro	C$11.30M	1.80	C$0.07 per share	3.94	C$0.38 per share	0.68

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CZO Ceapro	-C$2.81M	-C$0.03	N/A	∞	N/A	-24.86%	-9.09%	-6.91%	5/23/2024 (Estimated)

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CZO Ceapro	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CZO Ceapro	7.82	11.00	18.88

Ownership

Institutional Ownership

Company	Institutional Ownership
CZO Ceapro	N/A

Insider Ownership

Company	Insider Ownership
CZO Ceapro	4.01%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
CZO Ceapro	N/A	78.29 million	N/A	Not Optionable

CDY, SCLP, and CZO Headlines

Source	Headline
	Universal Music Restructuring Continues, East Coast Labels Unite via Republic Corps Division nz.finance.yahoo.com - March 12 at 2:31 PM
	A Complete Breakdown of Kate Middleton's Photoshop Controversy nz.finance.yahoo.com - March 12 at 2:31 PM
	Canadian Investment Regulatory Organization Trade Resumption - CZO finance.yahoo.com - December 14 at 12:56 PM
	Aeterna Zentaris and Ceapro Announce Merger of Equals to Create a Diversified Biopharmaceutical Company finance.yahoo.com - December 14 at 7:56 AM
	Ceapro Inc. Reports 2023 Third Quarter and Nine-Month Financial Results and Operational Highlights finance.yahoo.com - November 29 at 10:28 AM
	PSA: Charlotte Tilbury's Mystery Box is back, and there's a huge surprise in store nz.finance.yahoo.com - November 27 at 10:38 AM
	Ceapro Inc. Initiates Phase 1-2a Study Assessing Its Flagship Product Avenanthramides for Potential Applications in Inflammation Based Diseases finance.yahoo.com - November 27 at 10:38 AM
	Closing Bell: Ceapro Inc flat on Wednesday (CZO) theglobeandmail.com - September 14 at 12:42 PM
	Ceapro Inc. (CZO.V) ca.finance.yahoo.com - September 6 at 6:56 AM
	Ceapro Extends Exclusive International Supply and Distribution Agreement with Leading Global ... bakersfield.com - August 27 at 7:07 PM
	Closing Bell: Ceapro Inc up on Wednesday (CZO) theglobeandmail.com - August 3 at 4:50 AM
	Are Ceapro Inc.'s (CVE:CZO) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness? finance.yahoo.com - July 30 at 8:41 AM
	Closing Bell: Ceapro Inc down on Wednesday (CZO) theglobeandmail.com - July 19 at 6:07 PM
	Ceapro to Participate in the Virtual Investor Summer Spotlight Series kentuckytoday.com - July 5 at 10:10 AM
	Ceapro Inc. Reports Financial Results for First Quarter 2023 and Provides Corporate Update stockhouse.com - May 25 at 10:32 AM
	Closing Bell: Ceapro Inc up on Friday (CZO) theglobeandmail.com - May 13 at 10:36 AM
	Closing Bell: Ceapro Inc down on Tuesday (CZO) theglobeandmail.com - May 3 at 8:55 AM
	Ceapro Announces Positive Findings Demonstrating Oat Derived Beta Glucan and Avenanthramides Promote Wound Healing and Tissue Regeneration finance.yahoo.com - May 3 at 8:55 AM
	Closing Bell: Ceapro Inc down on Friday (CZO) theglobeandmail.com - April 22 at 12:33 AM
	Closing Bell: Ceapro Inc up on Thursday (CZO) theglobeandmail.com - April 21 at 9:32 AM
	Closing Bell: Ceapro Inc up on Tuesday (CZO) theglobeandmail.com - April 19 at 1:47 AM
	Ceapro Inc. Reports Record 2022 Financial Results and Operational Highlights finance.yahoo.com - April 12 at 9:16 AM
	Closing Bell: Ceapro Inc down on Monday (CZO) theglobeandmail.com - April 11 at 9:55 AM
	Closing Bell: Ceapro Inc flat on Thursday (CZO) theglobeandmail.com - April 6 at 6:54 PM

Media Sentiment Over Time

Company Descriptions

Ceapro

CVE:CZO

Ceapro Inc., a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries. It also offers natural active ingredients, including oat powder, oat oil, oat peptides, and lupin peptides to the personal care, cosmetic, medical, and animal health industries; anti-aging skincare products to the cosmeceutical industries; and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner. The company has a research collaboration with the Angiogenesis Foundation. The company was incorporated in 1997 and is headquartered in Edmonton, Canada.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial